Amarin Corp Plc (AMRN)

[md3434]

Raf and Board, the question that I have pondered for the past 9+ years is whether governments and insurance companies have calculated the cost of keeping overweight and generally unhealthy people alive that would have normally died without Vascepa. I know it has been discussed many times the average cost savings of not having a coronary event by being on Vascepa but is there a chance that total costs for other health issues exceed the costs related to a coronary event over time and they are each making their decisions like insurance companies do by using their calculators and their bottom lines?